Posts by: Patricia Inacio PhD

Patricia Inacio PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

February 22, 2021February 22, 2021

Blackfynn Acquires Therapy Potentially Ready for Phase 3 Testing

News

Blackfynn announced that its is acquiring the rights to a candidate Parkinson’s disease treatment that others gave up on but is thought ready to move into pivotal Phase 3 testing. Neither the ... Read more

February 10, 2021February 10, 2021

Potential ASO Therapies for Patients With GBA Mutations Ready for Testing

News

Q-State Biosciences has developed a set of optimized antisense oligonucleotides (ASOs) that may serve as potential therapies for Parkinson’s disease patients with specific mutations, the company announced. These ASO candidates are ... Read more

February 3, 2021February 3, 2021

Animal Work Into Stem Cell Treatment for Parkinson’s Honored by Journal

News

A scientist at the University of Latvia claimed a journal’s Young Investigator Award for her research showing how small vesicles derived from stem cells could lessen motor symptoms in a rat ... Read more

January 25, 2021January 25, 2021

Vercise Genus, 4th-generation DBS Treatment, Coming Soon to US

News

Vercise Genus, a fourth-generation system for deep brain stimulation (DBS) to treat people with Parkinson’s disease, is now available in the U.S., Boston Scientific, which markets the system, announced. The U.S. Food and ... Read more

December 9, 2020December 9, 2020

Spiroco 4mg Prolonged-release XL Tablets Discontinued

News

Teva has discontinued Spiroco (ropinirole) 4mg XL prolonged-release tablets due to factors out of the company’s control, according to an announcement from Parkinson’s UK. The company — which outside the U.S. ... Read more

November 3, 2020November 5, 2020

Two Small Trials Evaluating Focused Ultrasound in Treating Parkinson’s

News

Two small clinical trials are assessing MRI-guided focused ultrasound as a nonsurgical alternative for targeting the striatum — a brain region involved in voluntary movement control — to better treat Parkinson’s patients ... Read more

October 29, 2020October 29, 2020

Holding to Mediterranean Diet Lowers Parkinson’s Risk for Women, Study Finds

News

Women who adhere closely to a Mediterranean diet in their 30s and 40s have a lower risk of Parkinson’s disease later in life, particularly once they reach their mid-60s, a large population-based ... Read more

October 28, 2020October 28, 2020

Skin Samples May Aid Early Diagnosis of Parkinson’s, Study Suggests

News

A new method, originally developed to diagnose mad cow disease, shows effectiveness in measuring the buildup of alpha-synuclein in the skin of Parkinson’s disease patients, a new study reports. According to ... Read more

October 27, 2020October 27, 2020

Non-invasive OpsisDx Diagnostic Test Awarded US Academy Research Grant

News

The Healthy Longevity Global Grand Challenge, founded by the U.S. National Academy of Medicine, has awarded a grant to develop Entopsis’ non-invasive, urine- and skin swab-based OpsisDx test for the ... Read more

October 22, 2020October 22, 2020

Imbalance of Fat Content in Brain Cells May Fuel Parkinson’s Progression, Study Asserts

News

In patients with Parkinson’s disease, dopamine-producing neurons and microglia cells — the “immune cells” of the brain — accumulate fatty molecules that may promote inflammation and disease progression, a new ... Read more